- Home
- POLA vs CNSP Comparison
POLA vs CNSP Comparison
Compare POLA & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | POLA | CNSP |
|---|---|---|
| Founded | 1979 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0M | 8.5M |
| IPO Year | 2016 | 2019 |
Fundamental Metrics
Financial Performance| Metric | POLA | CNSP |
|---|---|---|
| Price | $0.96 | $5.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 85.1K | 2.7K |
| Earning Date | 11-18-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.03 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $24,801,141.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3.14 | N/A |
| 52 Week Low | $1.03 | $1.90 |
| 52 Week High | $5.70 | $10.54 |
Technical Indicators
Market Signals| Indicator | POLA | CNSP |
|---|---|---|
| Relative Strength Index (RSI) | 28.85 | 50.16 |
| Support Level | N/A | $4.58 |
| Resistance Level | $1.93 | $5.52 |
| Average True Range (ATR) | 0.09 | 0.20 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 3.03 | 74.69 |
Price Performance
Historical ComparisonAbout POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Other Asia Pacific, Europe and Middle East, United Kingdom, and South Africa.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.